Späth-Schwalbe, Ernst <br/><br/>
Influence of amifostine on toxicity of CHOP in elderly patients with aggressive non-Hodgkin's lymphoma--a phase II study.  [electronic resource] 

 -  Anti-cancer drugs  Apr 2002 
 - 395-403 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0959-4973 
<br/><br/><label>Standard No.: </label>10.1097/00001813-200204000-00008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Amifostine--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cyclophosphamide--adverse effects<br/>Cytoprotection--drug effects<br/>Doxorubicin--adverse effects<br/>Female<br/>Humans<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Prednisone--adverse effects<br/>Treatment Outcome<br/>Vincristine--adverse effects